Health News
AstraZeneca turnaround is 3-4 year journey, says CEO
LONDON - Turning around drugmaker AstraZeneca will be a long haul, with a strategy of revamping research and boosting acquisitions set to take up to four years to pay off, its chief executive said on Tuesday.
Enroll America sets private outreach for Obamacare sign-up
WASHINGTON - Enroll America, a nonprofit group at the center of the political fight over President Barack Obama's healthcare reform law, launched a multi-state grassroots campaign on Tuesday to help sign up millions of uninsured Americans for health coverage in the coming months.
Call for overhaul of drug industry business model
LONDON - Pharmaceutical companies need to boost the benefits of drug research by working with regulators and healthcare providers to overhaul the way medicines are approved and paid for, a thinktank backed by investors says.
WHO urges tougher food marketing rules to curb childhood obesity
LONDON - The marketing of unhealthy foods to children has proven "disastrously effective", driving obesity by using cheap social media channels to promote fat-, salt- and sugar-laden foods, the World Health Organisation's Europe office said on Tuesday.
Outbreak of deadly piglet virus spreads to 13 U.S. states
CHICAGO - A swine virus deadly to young pigs, one never before seen in North America, is spreading rapidly across the United States and proving harder to control than previously believed.
Industry-backed studies more prominent at meetings
NEW YORK (Reuters Health) - Studies that are funded by pharmaceutical companies or involve industry-backed scientists tend to be more prominent at cancer meetings than independent studies, a new report suggests.
Obamacare-like groups tied to lower costs: study
NEW YORK (Reuters Health) - Large independent doctor practices that focus on primary care tend to spend less money and are more likely to meet guidelines for Americans on Medicare than smaller groups, according to a new study.
Past care tied to later treatment's success
NEW YORK (Reuters Health) - If a person doesn't have much success with one pain treatment, they may say the next one they try doesn't work so great either, suggests a new study from Germany.
FDA probes deaths of two patients on Lilly schizophrenia drug
- The U.S. Food and Drug Administration is investigating the cases of two individuals who died after injections with Eli Lilly and Co.'s long-acting treatment for schizophrenia, Zyprexa Relprevv.
MRI may help find infection from tainted injection
NEW YORK (Reuters Health) - Some people who received potentially contaminated steroid injections may benefit from a MRI to check for signs of infection, a new study suggests - even if they don't have obvious symptoms.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
